We are live on ! Find out more
JAZZ icon

Jazz Pharmaceuticals
JAZZ

480 hedge funds and large institutions have $6.97B invested in Jazz Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 183 increasing their positions, 160 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

14% more repeat investments, than reductions

Existing positions increased: 183 | Existing positions reduced: 160

0.86% more ownership

Funds ownership: 92% → 92.86% (+0.86%)

2% less capital invested

Capital invested by funds: $7.12B → $6.97B (-$152M)

4% less funds holding

Funds holding: 499 → 480 (-19)

18% less call options, than puts

Call options by funds: $19.5M | Put options by funds: $23.9M

21% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 68

Holders
480
Holders Change
-19
Holders Change %
-3.81%
% of All Funds
6.91%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.1%
New
54
Increased
183
Reduced
160
Closed
68
Calls
$19.5M
Puts
$23.9M
Net Calls
-$4.39M
Net Calls Change
-$11.9M

Top Buyers

1
Capital World Investors
Capital World Investors
California
+$175M
2
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$133M
3
CCM
Camber Capital Management
Massachusetts
+$58.2M
4
AQR Capital Management
AQR Capital Management
Connecticut
+$53.9M
5
VPC
Vestal Point Capital
New York
+$45.9M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$128M
2
Swedbank
Swedbank
Sweden
-$127M
3
AC
Armistice Capital
New York
-$80.1M
4
Morgan Stanley
Morgan Stanley
New York
-$73.3M
5
Millennium Management
Millennium Management
New York
-$69.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
101
New York State Common Retirement Fund
New York
$7.68M -$3.97M -32,371 -34%
Envestnet Asset Management
102
Envestnet Asset Management
Illinois
$7.64M +$686K +5,597 +10%
CB
103
Commerce Bank
Missouri
$7.23M +$599K +4,894 +9%
TI
104
Trexquant Investment
Connecticut
$7.09M +$276K +2,257 +4%
Schroder Investment Management Group
105
Schroder Investment Management Group
United Kingdom
$7.02M +$1.31M +10,698 +22%
KA
106
Kovack Advisors
Florida
$6.82M +$3.26M +26,628 +89%
Aberdeen Group
107
Aberdeen Group
United Kingdom
$6.76M -$8.33K -68 -0.1%
TPSF
108
Texas Permanent School Fund
Texas
$6.64M +$90.2K +736 +1%
FAF
109
Fjarde Ap-fonden
Sweden
$6.62M +$1.8M +14,700 +37%
Amundi
110
Amundi
France
$6.58M -$1.61M -13,181 -18%
A
111
AustralianSuper
Australia
$6.58M +$6.78M +55,329 New
RJA
112
Raymond James & Associates
Florida
$6.44M +$2.52M +20,593 +63%
VanEck Associates
113
VanEck Associates
New York
$6.22M -$3.22M -26,315 -34%
Hudson Bay Capital Management
114
Hudson Bay Capital Management
Connecticut
$6.02M +$4.58M +37,400 +297%
WorldQuant Millennium Advisors
115
WorldQuant Millennium Advisors
New York
$5.87M -$14.2M -116,185 -70%
DB
116
Danske Bank
Denmark
$5.78M +$5.87M +47,958 New
Bank of Nova Scotia
117
Bank of Nova Scotia
Ontario, Canada
$5.66M +$4.39M +35,860 +322%
GC
118
Guggenheim Capital
Illinois
$5.62M +$168K +1,371 +3%
JFG
119
Jefferies Financial Group
New York
$5.62M -$467K -3,815 -8%
VOYA Investment Management
120
VOYA Investment Management
Georgia
$5.42M -$1.51M -12,352 -22%
SEI Investments
121
SEI Investments
Pennsylvania
$5.36M -$67.1K -548 -1%
Prudential Financial
122
Prudential Financial
New Jersey
$5.26M +$446K +3,640 +9%
Susquehanna International Group
123
Susquehanna International Group
Pennsylvania
$5.16M -$3.68M -30,049 -41%
SGAM
124
Smith Group Asset Management
Texas
$5.14M -$2.48M -20,270 -32%
RPI
125
Railway Pension Investments
United Kingdom
$5.13M – – –
3 4
5
6 7

JAZZ Hedge Fund Activity: Q1 2024 in Review

480 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Jazz Pharmaceuticals (JAZZ) for Q1 2024, worth a combined $6.97B — down 2.1% from $7.12B a quarter earlier.

Sellers outnumbered buyers: 68 funds closed out of JAZZ and 54 opened new positions — a net loss of 14 holders — while 160 trimmed existing stakes and 183 added.

The largest buyer was Capital World Investors, opening a new position worth an estimated $175M. The largest seller was Wellington Management Group, cutting an estimated $128M.

  • 480 institutional investors held Jazz Pharmaceuticals (JAZZ) as of Q1 2024, down from 499 in Q4 2023.
  • Funds reported $6.97B of Jazz Pharmaceuticals stock for Q1 2024, down 2.1% quarter-over-quarter.
  • 54 funds opened new Jazz Pharmaceuticals positions in Q1 2024 and 68 closed out, a net change of -14 holders.
  • The largest Jazz Pharmaceuticals buyer in Q1 2024 was Capital World Investors, an estimated $175M added.
  • The largest Jazz Pharmaceuticals seller in Q1 2024 was Wellington Management Group, an estimated $128M sold.

Based on aggregated 13F filings for Q1 2024.